Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-Pfs25 human plasma reduces transmission of Plasmodium falciparum isolates that have diverse genetic backgrounds.

Infection and immunity - 1 Jun 2013

Da Dari F, Dixit Saurabh, Sattabonkot Jetsumon, Mu Jianbing, Abate Luc, Ramineni Bhanumati, Ouedraogo Jean Bosco, MacDonald Nicholas J, Fay Michael P, Su Xin-zhuan, Cohuet Anna, Wu Yimin

Abstract excerpt

Pfs25 is a leading candidate for a malaria transmission-blocking vaccine whose potential has been demonstrated in a phase 1 trial with recombinant Pfs25 formulated with Montanide ISA51. Because of limited sequence polymorphism, the anti-Pfs25 antibodies induced by this vaccine are likely to have transmission-blocking or -reducing activity against most, if not all, field isolates. To test this hypothesis, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anopheles
Share to Antibodies, Protozoan

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Burkina Faso

Share to Immune Sera

Share to Malaria, Falciparum

Share to Malaria Vaccines

Share to Plasmodium falciparum

Share to Thailand

Source

Open in PubMed Open full text

Identifiers

PMID: 23509152
DOI: 10.1128/IAI.00016-13
PMCID: PMC3676035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-Pfs25 human plasma reduces transmission of Plasmodium falciparum isolates that have diverse genetic backgrounds.PMID 23509152Read ↗

Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate.Semantic proximity Read ↗

Global Diversity of the Gene Encoding the Pfs25 Protein - A Plasmodium Falciparum Transmission-Blocking Vaccine CandidateSemantic proximity Read ↗

Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoesSemantic proximity Read ↗

Genetic diversity of the Plasmodium falciparum Pfs230 gene in four East African countries supports its potential as a malaria transmission‑blocking vaccine candidate.Semantic proximity Read ↗

A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responsesSemantic proximity Read ↗

Sequence Polymorphism in Two Novel Plasmodium vivax Ookinete Surface Proteins, Pvs25 and Pvs28, That Are Malaria Transmission-blocking Vaccine CandidatesSemantic proximity Read ↗

Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China.Semantic proximity Read ↗

Genetic diversity of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax isolates from China.Semantic proximity Read ↗

Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking ActivitySemantic proximity Read ↗

Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivaxSemantic proximity Read ↗

Pooled Amplicon Deep Sequencing of Candidate Plasmodium falciparum Transmission-Blocking Vaccine Antigens.Semantic proximity Read ↗

Signatures of selection and drivers for novel mutation on transmission-blocking vaccine candidate Pfs25 gene in western Kenya.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.